Community Healthcare Trust (CHCT) director adds 8,000 shares in open-market buy
Rhea-AI Filing Summary
Community Healthcare Trust Inc director Robert Z. Hensley purchased 8,000 shares of common stock on August 11, 2026. The weighted average purchase price was $15.21 per share, with individual trade prices ranging from $15.14 to $15.27. Following this open-market transaction, Hensley directly owns 103,702 shares of Community Healthcare Trust Inc common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 8,000 shares
Net Buy
1 txn
Insider
Hensley Robert Z
Role
Director
Bought
8,000 shs ($122K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1 | 8,000 | $15.21 | $122K |
Holdings After Transaction:
Common Stock — 103,702 shares (Direct)
Footnotes (1)
- F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.14 to $15.27. The reporting person undertakes to provide Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) of this Form 4.
Key Figures
Shares purchased: 8,000 shares
Weighted average price: $15.21 per share
Price range: $15.14–$15.27 per share
+2 more
5 metrics
Shares purchased
8,000 shares
Common stock purchased on August 11, 2026
Weighted average price
$15.21 per share
Average price for 8,000-share common stock purchase
Price range
$15.14–$15.27 per share
Range of prices for multiple purchase transactions
Post-transaction holdings
103,702 shares
Direct ownership of common stock after the purchase
Approximate transaction value
$121,680
8,000 shares at $15.21 weighted average price
Key Terms
weighted average price, Form 4, open market or private transaction
3 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Form 4 regulatory
"within the ranges set forth in footnote (1) of this Form 4."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
open market or private transaction financial
"transaction code description: Purchase in open market or private transaction"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did CHCT director Robert Z. Hensley report?
Robert Z. Hensley reported a purchase of 8,000 CHCT common shares on August 11, 2026. The transaction was an open-market or private purchase at a weighted average price of $15.21 per share.
At what prices did Robert Z. Hensley buy CHCT stock?
Hensley bought CHCT shares at prices ranging from $15.14 to $15.27 per share. The reported price of $15.21 is a weighted average across multiple individual trades within that range.
What is the total value of Robert Z. Hensley’s recent CHCT stock purchase?
Based on the weighted average price of $15.21 per share, Hensley’s purchase of 8,000 CHCT shares represents an aggregate transaction value of approximately $121,680, excluding any commissions or fees not disclosed here.
Was Robert Z. Hensley’s CHCT trade under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not marked as an affirmative plan trade. No footnote states that this 8,000-share purchase was executed pursuant to a Rule 10b5-1 trading arrangement.